Stay updated on Pembrolizumab for Recurrent Glioblastoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Recurrent Glioblastoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Recurrent Glioblastoma Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    No significant changes detected in the page contents or structure between screenshots; the primary study details remain the same.
    Difference
    0.4%
    Check dated 2025-10-27T21:11:16.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    Version bump to v3.2.0 accompanied by a government-operating-status notice; replaces the earlier v3.1.0 tag.
    Difference
    3%
    Check dated 2025-10-06T08:57:39.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Updated the site/page version from v3.0.2 to v3.1.0, indicating a new release without other substantive content changes.
    Difference
    0.1%
    Check dated 2025-09-29T07:34:06.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    Page updated to revision v3.0.2; v3.0.1 is removed, and the Back to Top link is deleted. No observable changes to core content, pricing, stock, or time slots.
    Difference
    0.2%
    Check dated 2025-09-14T23:23:49.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-07T20:11:02.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location, while several medical terms and location details have been removed.
    Difference
    1%
    Check dated 2025-08-31T12:53:21.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Recurrent Glioblastoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Recurrent Glioblastoma Clinical Trial page.